NEW YORK (GenomeWeb) – Toronto-based SQI Diagnostics continues to see its CustomPlex diagnostic tools and services business generate revenue as interest in its technology from pharmaceutical industry partners increases.

The company said earlier this month that it had generated $32,000 in revenues in its fiscal third quarter, which ended on June 30, and $52,000 during the nine months preceding that date. While the sums may seem modest to some, it's worth noting that the firm reported no revenues in either the quarter or the first six months of fiscal 2013.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.